Correlation Between Aquestive Therapeutics and Avadel Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Avadel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Avadel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aquestive Therapeutics and Avadel Pharmaceuticals PLC, you can compare the effects of market volatilities on Aquestive Therapeutics and Avadel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Avadel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Avadel Pharmaceuticals.

Diversification Opportunities for Aquestive Therapeutics and Avadel Pharmaceuticals

0.72

Correlation Coefficient

Aquestive Therapeutics  Avadel Pharmaceuticals

Poor diversification

The 3 months correlation between Aquestive and Avadel is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Avadel Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avadel Pharmaceuticals and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Avadel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avadel Pharmaceuticals has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Avadel Pharmaceuticals go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and Avadel Pharmaceuticals

Given the investment horizon of 90 days Aquestive Therapeutics is expected to under-perform the Avadel Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Aquestive Therapeutics is 1.17 times less risky than Avadel Pharmaceuticals. The stock trades about -0.11 of its potential returns per unit of risk. The Avadel Pharmaceuticals PLC is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest  1,269  in Avadel Pharmaceuticals PLC on September 25, 2024 and sell it today you would lose (246.00) from holding Avadel Pharmaceuticals PLC or give up 19.39% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Aquestive Therapeutics  vs.  Avadel Pharmaceuticals PLC

Aquestive Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aquestive Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Avadel Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Avadel Pharmaceuticals PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Aquestive Therapeutics and Avadel Pharmaceuticals

The main advantage of trading using opposite Aquestive Therapeutics and Avadel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Avadel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avadel Pharmaceuticals will offset losses from the drop in Avadel Pharmaceuticals' long position.

The idea behind Aquestive Therapeutics and Avadel Pharmaceuticals PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.